NCT05808803View on ClinicalTrials.gov

Aberrant Myeloid Lineage Differentiation in HIV/AIDS Patients

CompletedOBSERVATIONAL

Enrollment

782

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

October 31, 2020

Study Completion Date

January 31, 2022

Conditions

HIV InfectionsLeukemia

All Listed Sponsors

lead

Zhongnan Hospital

OTHER

NCT05808803 - Aberrant Myeloid Lineage Differentiation in HIV/AIDS Patients | Biotech Hunter | Biotech Hunter